Today’s CSR movers
PEP 3.0 —
HLT 4.0 —
CPRT 3.9 —
XEL 4.8 —
CRL 4.0 —
ZTS 3.6 —
—
—
Health Care · NYSE NYSE · WAT

Waters Corporation

$436.61 +$7.55 +1.73% CLOSE 10.14.26 AFTER HOURS $436.61
Convergence score
4.0 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$454.42 +4.1%
Range $345.00 — $530.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 10.14.26
UV Convergence Score
REPORT 10.14.26
4.0
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Analyst average
4.4
Multi-signal aggregate How CSR works →
Day Range
$429.89 – $441.89
52W Range
$282.77 – $454.54
Volume
901.4K
Avg Vol
799.7K
Mkt Cap
$42.87B
P/E
110.53
EPS (TTM)
$3.95
Div Yield
0.00%
Beta
1.15
Today's convergence

Convergence score sits at 4.0 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$436.61
Sector
Health Care
Valuation
Three horizons
UPDATED 10.14.26
Short term
0–3 MO
No target —
Medium term
3–12 MO
$444+1.6% Buy
Long term
12–36 MO
$158.38-63.7% Overvalued
Open valuation →
Analysts
Coverage & consensus
3 PANELS
Mean target (12mo)
$454.42 +4.1%
RANGE $345.00 — $530.00
Analyst consensus
Consensus rating Buy
Blended score 4.1 / 5
Analysts tracked 66
Open analysts →
Financials
Key metrics
LATEST
P/E
110.53
EPS (TTM)
$3.95
Mkt Cap
$42.87B
Div Yield
0.00%
Beta
1.15
52W Range
$282.77 – $454.54
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 10.14.26
Short term
0–3 MO
—
Consensus target
No target available
Medium term
3–12 MO
Buy
Consensus target
$444 +1.6%
RANGE $345 – $515
$345NOW $436.61$515

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$158.38 -63.7%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 10.14.26
Analyst consensus
Rating Blended score Panels Analysts
Buy 4.1 3 66
Price targets
Coverage Low Mean Median High Upside
All panels $345.00 $454.42 $465.00 $530.00 +4.1%
Rating distribution
Coverage SB B H S SS
All panels 5 26 12 0 0
Rating trend
Period Rating Avg Analysts
Current — — —
1 Mo Ago — — —
2 Mo Ago — — —
3 Mo Ago — — —
Most recent analyst action
Date
10/13/2026
Firm
TD Cowen
Action
Boost Target
Rating
Buy
Target
$515.00
Financials

Full financial snapshot.

UPDATED 10.14.26
Quote snapshot
Prev Close
$429.17
Open
$430.88
Day Low
$429.89
Day High
$441.89
Bid
$423.13
Ask
$443.69
52W Low
$282.77
52W High
$454.54
50D Avg
$418.09
200D Avg
$365.42
Volume
901.4K
Avg Vol
799.7K
10D Avg Vol
908.1K
52W Change
29.11%
S&P 52W Change
17.00%
Valuation ratios
P/E (TTM)
110.53
P/E (Fwd)
26.41
PEG (Fwd)
1.60
P/S
9.23
P/B
2.82
Book Value
$154.70
EV/Revenue
10.30
EV/EBITDA
32.94
Mkt Cap
42.87B
Enterprise Val
47.83B
Profitability & returns
Profit Margin
3.59%
Gross Margin
56.34%
Operating Margin
9.42%
EBITDA Margin
31.26%
Return on Assets
3.56%
Return on Equity
1.92%
Growth
Revenue Growth (YoY)
113.40%
Earnings Growth (YoY)
—
Earnings Growth (Q)
—
Balance sheet & cash flow
Total Revenue
4.64B
EBITDA
1.45B
Total Cash
539M
Total Debt
5.48B
Cash / Share
$5.49
Revenue / Share
$62.10
Free Cash Flow
-142.07M
Operating CF
549.56M
Debt / Equity
36.05
Current Ratio
1.86
Quick Ratio
1.05
Dividend
Fwd Dividend
—
Dividend Yield
0.00%
Payout Ratio
0.00%
5Y Avg Yield
—
Ex-Div Date
1996-11-26
Share statistics
Shares Out
98.19M
Float
98.07M
Shares Short
3.4M
% Short of Float
3.47%
Short Ratio
5.00
% Held Insiders
0.10%
% Held Institutions
102.09%
Calendar & events
Next Earnings
2026-11-03
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-07-04
Last Split
2:1
Split Date
2000-08-28
Company
Industry
Diagnostics & Research
Employees
16,000